In the present study, we observed highly variable effects of ASA on in vitro-treated PBLs from MCAD patients in terms of no effect, elevation, and reduction of PBL-derived PGD2 and pLT release, with both same and opposing effects. This evidence concerns the gene PTGDS and medium chain acyl-CoA dehydrogenase deficiency.